Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanuel Oger

Showing results (71-80 of 181) with videos related to

Pageof 19
Sort By:
Heart and Vessels|December 29, 2016
The prognostic significance of atrial fibrillation in heart failure with preserved ejection function: insights from KaRen, a prospective and multicenter studyChristian Bosseau, Erwan Donal, Lars H Lund, et al.
International Journal of Cardiology|October 28, 2016
Changes in natriuretic peptides after acute hospital presentation for heart failure with preserved ejection fraction: A feasible surrogate trial endpoint? A report from the prospective Karen studyGianluigi Savarese, Erwan Donal, Camilla Hage, et al.
International Journal of Cardiology|April 1, 2018
Corrigendum to "Changes in natriuretic peptides after acute hospital presentation for heart failure with preserved ejection fraction: A feasible surrogate trial endpoint? A report from the prospective Karen study" [Int. J. Cardiol. 226 (2017) 65-70]Gianluigi Savarese, Erwan Donal, Camilla Hage, et al.
Journal of Patient Safety|May 5, 2021
The Trigger Tool Method for Routine Pharmacovigilance: A Retrospective Cohort Study of the Medical Records of Hospitalized Geriatric PatientsFloriane Marseau, Joaquim Prud'Homm, Guillaume Bouzillé, et al.
Clinical Cardiology|November 10, 2023
Primary mitral regurgitation: Toward a better quantification on left ventricular consequencesAntoine Neveu, Samy Aghezzaf, Emmanuel Oger, et al.
International Journal of Cardiology|July 28, 2018
Importance of structural heart disease and diastolic dysfunction in heart failure with preserved ejection fraction assessed according to the ESC guidelines - A substudy in the Ka (Karolinska) Ren (Rennes) studyHans Persson, Erwan Donal, Lars H Lund, et al.
Gastroenterologie Clinique Et Biologique|April 20, 2004
Factors associated with liver steatosis and fibrosis in chronic hepatitis C patientsFranck Cholet, Jean-Baptiste Nousbaum, Martial Richecoeur, et al.
European Heart Journal. Cardiovascular Imaging|June 18, 2015
Value of exercise echocardiography in heart failure with preserved ejection fraction: a substudy from the KaRen studyErwan Donal, Lars H Lund, Emmanuel Oger, et al.
BMJ Open|September 21, 2022
Oral Janus kinase inhibitors and venous thromboembolic events in atopic dermatitis: protocols for a case-time control study and a nested case-control study based on the French national health insurance (SNDS) cohortPauline Berthe, Lucie-Marie Scailteux, Alain Lescoat, et al.
European Heart Journal. Cardiovascular Imaging|July 16, 2024
Right atrial and right ventricular strain: prognostic value depends on the severity of tricuspid regurgitationElizabeth Curtis, Léo Lemarchand, K Charlotte Lee, et al.
Pageof 19

Showing results (71-80 of 181) with videos related to

Sort By:
Pageof 19
Heart and Vessels|December 29, 2016
The prognostic significance of atrial fibrillation in heart failure with preserved ejection function: insights from KaRen, a prospective and multicenter studyChristian Bosseau, Erwan Donal, Lars H Lund, et al.
International Journal of Cardiology|October 28, 2016
Changes in natriuretic peptides after acute hospital presentation for heart failure with preserved ejection fraction: A feasible surrogate trial endpoint? A report from the prospective Karen studyGianluigi Savarese, Erwan Donal, Camilla Hage, et al.
International Journal of Cardiology|April 1, 2018
Corrigendum to "Changes in natriuretic peptides after acute hospital presentation for heart failure with preserved ejection fraction: A feasible surrogate trial endpoint? A report from the prospective Karen study" [Int. J. Cardiol. 226 (2017) 65-70]Gianluigi Savarese, Erwan Donal, Camilla Hage, et al.
Journal of Patient Safety|May 5, 2021
The Trigger Tool Method for Routine Pharmacovigilance: A Retrospective Cohort Study of the Medical Records of Hospitalized Geriatric PatientsFloriane Marseau, Joaquim Prud'Homm, Guillaume Bouzillé, et al.
Clinical Cardiology|November 10, 2023
Primary mitral regurgitation: Toward a better quantification on left ventricular consequencesAntoine Neveu, Samy Aghezzaf, Emmanuel Oger, et al.
International Journal of Cardiology|July 28, 2018
Importance of structural heart disease and diastolic dysfunction in heart failure with preserved ejection fraction assessed according to the ESC guidelines - A substudy in the Ka (Karolinska) Ren (Rennes) studyHans Persson, Erwan Donal, Lars H Lund, et al.
Gastroenterologie Clinique Et Biologique|April 20, 2004
Factors associated with liver steatosis and fibrosis in chronic hepatitis C patientsFranck Cholet, Jean-Baptiste Nousbaum, Martial Richecoeur, et al.
European Heart Journal. Cardiovascular Imaging|June 18, 2015
Value of exercise echocardiography in heart failure with preserved ejection fraction: a substudy from the KaRen studyErwan Donal, Lars H Lund, Emmanuel Oger, et al.
BMJ Open|September 21, 2022
Oral Janus kinase inhibitors and venous thromboembolic events in atopic dermatitis: protocols for a case-time control study and a nested case-control study based on the French national health insurance (SNDS) cohortPauline Berthe, Lucie-Marie Scailteux, Alain Lescoat, et al.
European Heart Journal. Cardiovascular Imaging|July 16, 2024
Right atrial and right ventricular strain: prognostic value depends on the severity of tricuspid regurgitationElizabeth Curtis, Léo Lemarchand, K Charlotte Lee, et al.
Pageof 19